The Budget Impact Of Introducing A PD-L1 Assay To Select Patients With Metastatic Nsclc Who Are Potential Candidates For Treatment With Immune Checkpoint Inhibitors
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1007
https://www.valueinhealthjournal.com/article/S1098-3015(17)31341-4/fulltext
Title :
The Budget Impact Of Introducing A PD-L1 Assay To Select Patients With Metastatic Nsclc Who Are Potential Candidates For Treatment With Immune Checkpoint Inhibitors
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31341-4&doi=10.1016/j.jval.2017.08.1007
First page :
A576
Section Title :
HEALTH CARE TREATMENT STUDIES
Open access? :
No
Section Order :
960